KOD Kodiak Sciences Inc.
KOD Kodiak Sciences Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-17 1 neutral converging
POC $23.79 · VWAP $28.08 · +45.9% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
KOD Price Structure
Loading timeframes…
Peers
Every watchlist KOD belongs to, members best 30-day change first — KOD highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-03-31: diluted EPS $-0.94, net income $-58M (SEC filing). Across the print the stock moved -2.0% (close before → first close after).
full note →Against street estimates
How KOD's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about KOD from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
- Kodiak Sciences (KOD) Earnings Report: Key Numbers & Transcript Summary
- Kodiak Sciences (KOD) Earnings Date and Reports 2026
- KOD Q1 2026 Earnings: EPS Beat Despite No Revenue; Stock ...
- Kodiak Sciences posts Q4 loss, cash into 2027 | KOD Stock News
- Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
KOD research tape
24 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.